Kewaunee Scientific CORP /DE/ Form 4 insider transactions

Ryan S. Noble, VP-Sales & Marketing-Americas at Kewaunee Scientific Corp, reported the vesting of restricted stock units and a subsequent sale of shares for tax withholding purposes.

Mandar Ranade, VP of Information Technology at Kewaunee Scientific Corp, reported the acquisition of 2,966 common shares through restricted stock unit vesting and the subsequent disposition of 1,298 shares for tax purposes.

Douglas J. Batdorff, VP of Manufacturing Operations at Kewaunee Scientific Corp, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.

Kewaunee Scientific's Chief Financial Officer, Donald T. Gardner III, converted various restricted stock units into common stock and subsequently sold a portion of these shares to cover tax liabilities.

Elizabeth D. Phillips, VP of Human Resources at Kewaunee Scientific Corp, reported the vesting of 2,733 restricted stock units and the subsequent sale of 1,196 shares for tax withholding purposes.

Thomas David Hull III, President, CEO, and Director of Kewaunee Scientific Corp, reported the vesting of 12,130 restricted stock units and the subsequent disposition of 3,483 shares for tax withholding purposes.

Kewaunee Scientific Corp's President and CEO, Thomas David Hull III, has been granted 25,328 restricted stock units, aligning his compensation with future company performance.

Donald T. Gardner III, Chief Financial Officer of Kewaunee Scientific Corp, was granted 9,047 Restricted Stock Units (RSUs) on June 25, 2025, with vesting tied to both service and performance conditions.

Douglas J. Batdorff, VP of Manufacturing Operations at Kewaunee Scientific Corp, was granted 4,528 restricted stock units, aligning executive incentives with company performance and long-term employment.

Ryan S. Noble, VP-Sales & Marketing-Americas at Kewaunee Scientific Corp, has been granted 4,380 Restricted Stock Units (RSUs) as part of an equity compensation award.

Mandar Ranade, VP of Information Technology at Kewaunee Scientific Corp, has been granted 4,392 restricted stock units, vesting based on service and performance over a multi-year period.

Elizabeth D. Phillips, VP of Human Resources at Kewaunee Scientific Corp, has been granted 4,111 Restricted Stock Units (RSUs) under a new compensation award.

Director Margaret B Pyle reports acquisition of 1,896 shares of Kewaunee Scientific Corp common stock as part of her annual director compensation.

Director John Russell acquired 1,896 shares of Kewaunee Scientific Corp common stock on May 7, 2025, as part of his annual compensation.

Director Keith M Gehl acquired 1,896 shares of Kewaunee Scientific Corp common stock as part of his annual compensation.

Kewaunee Scientific Corp's CEO, Thomas David Hull III, sold 1,844 shares of common stock at an average price of $32.44 on April 14, 2025.

Donald T. Gardner III, CFO of Kewaunee Scientific Corp, sold a total of 4,000 shares of common stock in multiple transactions on April 9 and 10, 2025.

Director Keith M Gehl of Kewaunee Scientific Corp /DE/ (KEQU) purchased 1,000 shares of common stock at $35 per share on April 4, 2025, increasing his holdings to 18,500 shares.

Donald T. Gardner III, CFO of Kewaunee Scientific Corp, sold a total of 3,000 shares of common stock on March 26, 2025, in multiple transactions.

Director Keith M Gehl of Kewaunee Scientific Corp purchased 500 shares of common stock at $45 per share on March 24, 2025.

CEO Thomas David Hull III sold a total of 3,213 shares of Kewaunee Scientific Corp (KEQU) common stock in multiple transactions on March 21 and March 24, 2025.

Director Keith M Gehl of Kewaunee Scientific Corp purchased 403 shares of common stock at $49 per share on March 18, 2025.

Margaret B. Pyle, a director of Kewaunee Scientific Corp, reported gifting 740 shares of common stock to her children on March 6, 2025.

Donald T. Gardner III, CFO of Kewaunee Scientific Corp, sold 1,257 shares of common stock at an average price of $59.26 on January 10, 2025.

Kewaunee Scientific Corp's CEO, Thomas David Hull III, sold 1,368 shares of common stock at a weighted average price of $60.08 on January 10, 2025.

Ryan S. Noble, VP of Sales & Marketing-Americas at Kewaunee Scientific Corp, sold 1,500 shares of common stock on December 30, 2024.

A Kewaunee Scientific Corp executive, Douglas J. Batdorff, sold 3,470 shares of common stock at $65.5 per share on December 30, 2024.

Kewaunee Scientific Corp's CEO, Thomas David Hull III, sold 2,000 shares of common stock on December 26, 2024.

Donald T. Gardner III, CFO of Kewaunee Scientific Corp, sold a total of 2,050 shares of common stock on December 24, 2024, in multiple transactions at varying prices.

Elizabeth D. Phillips, VP of Human Resources at Kewaunee Scientific Corp, sold 1,850 shares of common stock on December 17, 2024.